Potential value of ctDNA monitoring in metastatic HR + /HER2-breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial

Chiu, J; Su, F; Joshi, M; Masuda, N; Ishikawa, T; Aruga, T; Zarate, JP; Babbar, N; Balbin, OA; Yap, YS

Yap, YS (通讯作者),Natl Canc Ctr Singapore, Div Med Oncol, 30 Hosp Blvd, Singapore, Singapore.

BMC MEDICINE, 2023; 21 (1):

Abstract

Background There is increasing interest in the use of liquid biopsies, but data on longitudinal analyses of circulating tumor DNA (ctDNA) remain relat......

Full Text Link